For examples, NRF2 signaling is suppressed during NAFLD development,[11, 12] and defects or loss of function mutations in the p53 pathway occurs in more than 50% of HCC patients.[13] How HCC cells cope with oxidative stress during NAFLD‐HCC progression remains largely unknown. The gene discussed is TP53; the disease is hepatocellular carcinoma.